Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1650 of 2400 entries
View as:

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

Phase: N/A Priority: Normal
NCT ID: NCT00459316 Org: User:
Start: 06/30/07 End: 03/31/13 Due: 03/31/14

Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies

Phase: N/A Priority: Normal
NCT ID: NCT03610802 Org: User:
Start: 07/22/19 End: 03/31/38 Due: 03/31/39

Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV

Phase: N/A Priority: Normal
NCT ID: NCT05781542 Org: User:
Start: 04/10/23 End: 04/14/25 Due: 04/14/26

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

Phase: N/A Priority: Normal
NCT ID: NCT00955006 Org: User:
Start: 05/31/11 End: 11/22/17 Due: 11/22/18

Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection

Phase: N/A Priority: Normal
NCT ID: NCT02225158 Org: User:
Start: 08/15/14 End: 05/11/17 Due: 05/11/18

Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI)

Phase: N/A Priority: Normal
NCT ID: NCT00001244 Org: User:
Start: 01/15/90 End: - Due: -

Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali

Phase: N/A Priority: Normal
NCT ID: NCT01168271 Org: User:
Start: 08/30/10 End: - Due: -

Genetic Analysis of Immune Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00001467 Org: User:
Start: 06/06/95 End: - Due: -

Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali

Phase: N/A Priority: Normal
NCT ID: NCT04329104 Org: User:
Start: 02/15/21 End: 07/05/23 Due: 07/05/24

Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU

Phase: N/A Priority: Normal
NCT ID: NCT00307099 Org: User:
Start: 10/31/06 End: 02/28/07 Due: 02/28/08

Eosinophilic Esophagitis Databank

Phase: N/A Priority: Normal
NCT ID: NCT01323803 Org: User:
Start: 04/30/11 End: 02/29/16 Due: 02/28/17

Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns

Phase: N/A Priority: Normal
NCT ID: NCT00006396 Org: User:
Start: - End: 11/30/04 Due: 11/30/05

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Phase: N/A Priority: Normal
NCT ID: NCT00001117 Org: User:
Start: - End: - Due: -

NIAID Clinical Center Genomics Opportunity Protocol

Phase: N/A Priority: Normal
NCT ID: NCT02417766 Org: User:
Start: 06/29/15 End: 01/22/19 Due: 01/22/20

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Phase: N/A Priority: Normal
NCT ID: NCT00071890 Org: User:
Start: 10/31/03 End: 12/31/07 Due: 12/31/08

Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02317900 Org: User:
Start: 12/31/14 End: - Due: -

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT00099632 Org: User:
Start: 03/31/06 End: 11/30/11 Due: 11/30/12

Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT02948127 Org: User:
Start: 09/30/16 End: 04/30/18 Due: 04/30/19

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

Phase: N/A Priority: Normal
NCT ID: NCT06919003 Org: User:
Start: 05/30/25 End: 05/30/32 Due: 05/30/33

Study of Tecovirimat for Human Mpox Virus

Phase: N/A Priority: Normal
NCT ID: NCT05534984 Org: User:
Start: 09/12/22 End: 09/30/25 Due: 09/30/26

Inpatient Influenza Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT00419861 Org: User:
Start: 11/30/06 End: 04/30/07 Due: 04/30/08

Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01381744 Org: User:
Start: 02/29/12 End: 08/31/14 Due: 08/31/15

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03389893 Org: User:
Start: 07/25/18 End: 09/09/20 Due: 09/09/21

Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area

Phase: N/A Priority: Normal
NCT ID: NCT03008122 Org: User:
Start: 03/21/17 End: 08/10/21 Due: 08/10/22

Characteristics of Mast Cells in Mastocytosis

Phase: N/A Priority: Normal
NCT ID: NCT00001356 Org: User:
Start: 05/31/93 End: 05/31/02 Due: 05/31/03